Acute myeloid leukaemia
A fast-growing cancer of the blood and bone marrow, in which the marrow makes large numbers of abnormal, immature white blood cells.1 It can cause tiredness, pale skin, shortness of breath, easy bleeding or bruising, and getting ill a lot.2 Treatment needs to start quickly and is mainly chemotherapy, sometimes with targeted medicines or a stem cell transplant.3 It can happen at any age, but it is more likely after 60, and the risk keeps rising with age.4
Read more about Acute myeloid leukaemiaTrial-stage treatments and research studies you can join
Filters
- Tests blinatumomab with chemotherapy and ponatinib in adults with leukemia
Tests blinatumomab, chemotherapy and ponatinib in adults with Philadelphia-positive acute lymphoblastic leukemia.
Houston, United StatesAge 18+ - Testing dexrazoxane to protect the heart during chemotherapy for blood cancers
Tests dexrazoxane to reduce heart side effects of chemotherapy in people with blood cancers.
Houston, United StatesAge 12+ - Tests a lower dose of cyclophosphamide after blood stem cell transplant
Tests a lower dose of cyclophosphamide to prevent graft-versus-host disease in blood cancer transplant patients.
Bethesda, United StatesAlso DuarteAge 12 to 120 - Tests whole genome sequencing alongside standard tests in leukemia and MDS
Tests whole genome sequencing with standard tests in adults with AML or MDS.
St Louis, United StatesAge 18+ - Testing New Treatment Combinations for Newly Diagnosed High-Risk Acute Myeloid Leukemia
Compares newer drug combinations with standard chemotherapy in adults with high-risk acute myeloid leukemia.
‘Aiea, United StatesAlso Albany, Albuquerque, Allentown, Anaconda, Ann Arbor, Appleton, Ashland, Augusta, …Age 18 to 59 - Tests modified immune T cells against CD33 in adults with acute myeloid leukemia
Tests modified immune cells that target CD33 in adults with returned or resistant leukemia.
Duarte, United StatesAge 18+ - Testing ziftomenib in acute myeloid leukemia patients who cannot receive standard therapy
Tests ziftomenib in adults with NPM1 or KMT2A acute myeloid leukemia.
Columbus, United StatesAge 18+ - Tests emapalumab with other drugs to prevent graft-versus-host disease after transplant
Tests emapalumab with other drugs in adults with leukemia or myelodysplastic syndrome.
Duarte, United StatesAge 18 to 75 - Tests CRD3874-SI for acute myeloid leukemia that has returned or not responded to treatment
Tests whether CRD3874-SI is safe in adults with acute myeloid leukemia.
Basking Ridge, United StatesAlso Commack, Harrison, Middletown, Montvale, New York, Rockville CentreAge 18+ - Venetoclax with chemotherapy for acute myeloid leukemia and related myeloid cancers
Tests venetoclax with chemotherapy in adults with acute myeloid leukemia.
Seattle, United StatesAge 18+ - Tests bleximenib with chemotherapy in newly diagnosed acute myeloid leukemia
Tests bleximenib added to chemotherapy in adults with NPM1 or KMT2A gene changes.
Atlanta, United StatesAlso Baltimore, Charlotte, Chicago, Cincinnati, Columbus, Kansas City, Los Angeles, Orlando, …Age 18+ - Shorter versus standard venetoclax with ASTX727 for older adults with newly diagnosed AML
Tests shorter versus standard venetoclax with ASTX727 in older adults with new AML.
Anaconda, United StatesAlso Baton Rouge, Bemidji, Billings, Bismarck, Bloomington, Brighton, Buffalo, Canton, …Age 60+ - ATRN-119 Plus Decitabine for TP53-Mutated Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndrome
Tests ATRN-119 with decitabine in adults with TP53-mutated leukemia or high-risk MDS.
St Louis, United StatesAge 18+ - Testing CHM-029 pill in adults with relapsed or hard-to-treat acute myeloid leukemia
Tests the new pill CHM-029 in adults with relapsed or hard-to-treat leukemia.
Duarte, United StatesAlso Grand Rapids, Nashville, New Haven, New YorkAge 18+ - Tests oral azacitidine to prevent relapse in adults with acute myeloid leukemia
Tests a pill form of azacitidine in adults with acute myeloid leukemia.
Richmond, United StatesAge 18+ - Revumenib with azacitidine and venetoclax for newly diagnosed KMT2A-rearranged acute myeloid leukemia
Tests revumenib, azacitidine and venetoclax in adults newly diagnosed with KMT2A-rearranged AML.
Chapel Hill, United StatesAge 18 to 65 - Testing Venetoclax Plus Azacitidine With or Without Gilteritinib for FLT3 Leukemia
Tests adding gilteritinib to venetoclax and azacitidine in older adults with FLT3-mutated leukemia.
‘Aiea, United StatesAlso Albany, Albuquerque, Allentown, Anaconda, Appleton, Ashland, Augusta, Basking Ridge, …Age 18+ - Compares venetoclax and gemtuzumab ozogamicin with chemotherapy for core binding factor leukemia
Compares two added medicines with chemotherapy in younger adults with new leukemia.
Albuquerque, United StatesAlso Anaconda, Baton Rouge, Bellevue, Billings, Birmingham, Boiling Springs, Boston, Bozeman, …Age 18 to 59 - Olutasidenib for Relapsed IDH1-Mutated Acute Myeloid Leukemia After Venetoclax Treatment
Tests olutasidenib in adults whose IDH1-mutated leukemia returned after venetoclax.
Winston-Salem, United StatesAge 18+ - Tests pexidartinib in young people with refractory leukemias and solid tumors
Tests pexidartinib in people aged 3 to 35 with leukemia or solid tumors.
Bethesda, United StatesAge 3 to 35
Where treatment stands
Where research stands now
On 11 November 2026, 835 trials and studies of acute myeloid leukemia were open. That day, 931 treatments were being tested in people: 110 had reached phase 3, the last trials before approval, 301 phase 2 and 266 phase 1. From 3 November 2025 to 11 November 2026, articles reported 128 treatment studies in people, 322 in animals and 157 in the lab. On 11 November 2026, 13 medicines had a US approval and 14 an EU approval for this disease. Health pages say it is sometimes curable; more than 1 in 4 adults live 3 years or more.
We found 34 medicines approved for acute myeloid leukaemia in the EU, the US, Switzerland or France, and 32 being tested in people.
Approved: 34
Officially approved for this disease in the EU, the US, Switzerland or France.
Human testing stage: 32
Being tested in people. Many treatments at this stage are never approved.
Animal testing stage: 5
Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.
Lab research stage: 2
Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.
Placebo: a dummy treatment without the medicine, used for comparison.
Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.
The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.
A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.
The EU medicines agency (EMA), ClinicalTrials.gov and the EU trials register, checked on 10 November 2026. Every treatment links to its own records; the texts are written by AI from them.
Medicines approved only in single countries are not included. We did not check in which countries a medicine is sold or paid for. Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 209 other open phase 2 trials are not listed.
Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for acute myeloid leukaemia. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.
Not medical advice. Talk to your doctor before you change any treatment.
Support organisations
Patient organisations and helplines in United States, for you and your family.
Acute myeloid leukaemia organisations in United States
- National Cancer Institute – Cancer Information Service (CIS)
NCI's contact center: information specialists answer cancer questions from patients, families and the public by phone, chat and email.
- American Cancer Society
Nationwide US nonprofit helping people who face cancer: research, patient services, early detection, treatment information and education, with a cancer helpline on its site.
- Cactus Cancer Society
Young adult cancer resource and community: support programs for people diagnosed with cancer as young adults.
- Cancer Hope Network
Nonprofit providing free one-on-one support to cancer patients and families by matching them with trained volunteers who have had a similar experience.
- Cancer Nation
Survivor-led US cancer advocacy organization (formerly the National Coalition for Cancer Survivorship) working on quality cancer care and survivorship resources.
- Genetic and Rare Diseases Information Center
NIH information center (GARD) providing reliable information on genetic and rare diseases to patients and families via website and contact center.
- HealthTree Foundation (HealthTree for AML / for Multiple Myeloma)
Free nonprofit platform for AML and myeloma: disease education, specialist and clinical-trial finders, patient navigators, trained patient/caregiver coaches, webinars and meetups (free account for some tools).
- Imerman Angels
Nonprofit offering free one-on-one cancer support and personalized mentoring that connects cancer fighters, survivors and caregivers with someone who has been there.
- Leukemia Research Foundation
Need-based financial assistance, peer support, AML guides for newly diagnosed patients, live Q&A sessions and webinars with leukaemia experts.
- NMDP (Be The Match) Patient Support Center
For patients needing a stem cell transplant: one-to-one patient navigators, financial assistance, group sessions and peer connection.
- Triage Cancer
National nonprofit providing free education on legal and practical issues (insurance, employment, finances) for people with cancer and caregivers.
General support in United States
- 988 Suicide & Crisis Lifeline
US national 24/7 free and confidential lifeline for anyone in suicidal crisis or emotional distress, reachable by calling or texting 988 or by chat.
- MedlinePlus
Free, easy-to-read health information service of the US National Library of Medicine (NIH) on diseases, conditions, drugs and wellness.
International organisations
Offer tissue or data
There are three ways to help research move faster.
Treatments approved outside the EU
Medicines for Acute myeloid leukaemia approved in the US or Japan that are not approved in the EU.
Checked on 11 Nov 2026 in the official lists of the US (FDA), Japan (PMDA, approvals since April 2004) and the EU (EMA). 6 uncertain matches are left out.
Your health insurer may pay part of the cost, sometimes all of it. This depends on your insurer, your plan and the country, so always ask your insurer before you go. For planned care in the EU, the EEA and Switzerland, ask about form S2.
“Miracle cure” fact checker
Social media spreads misinformation. Paste what you read here, and we'll tell you whether there is scientific evidence behind it.
What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.
Before you pay for anything, ask three things
- Is there a published study in people?
- Can I have the full price in writing?
- What does my doctor say?
“Cures” others already fact-checked
- CBD (cannabidiol) & Acute myeloid leukaemia
- Vitamin C (incl. high-dose) & Acute myeloid leukaemia
- Ivermectin & Acute myeloid leukaemia
- Fenbendazole & Acute myeloid leukaemia
About Acute myeloid leukaemia
A fast-growing cancer of the blood and bone marrow, in which the marrow makes large numbers of abnormal, immature white blood cells.1 It can cause tiredness, pale skin, shortness of breath, easy bleeding or bruising, and getting ill a lot.2 Treatment needs to start quickly and is mainly chemotherapy, sometimes with targeted medicines or a stem cell transplant.3 It can happen at any age, but it is more likely after 60, and the risk keeps rising with age.4
What is it?
AML is a rare cancer of the blood and bone marrow.4 Bone marrow, found in the centre of most bones, makes blood cells.1 In AML it makes large numbers of abnormal, immature white blood cells that crowd out the healthy ones.1 It is the most common type of acute leukaemia in adults. 'Acute' means it gets worse quickly, so treatment needs to start fast.1,3
It can happen at any age, but it is more likely after 60. Being male may also raise the risk.2,5,1 The risk is also higher if you smoke, had chemotherapy or radiotherapy in the past, have another blood disorder, have a genetic condition such as Down's syndrome, or were often exposed to high levels of the chemical benzene.5 It is not always clear what causes it.5
The first signs
The signs are often not obvious at first and can feel like flu.2,1 They usually come on quickly, over a few weeks:2
- feeling very tired or weak;2
- looking paler than usual (on brown or black skin, check the palms or the inside of the eyelids);2
- getting out of breath;2
- bleeding or bruising easily;2
- a high temperature, or getting ill a lot or taking longer than usual to recover from illnesses;2
- aching bones or joints, a swollen tummy or swollen glands.2
They can be caused by many other conditions, but they need checking.2
How doctors find out
Your family doctor usually arranges an urgent blood test, and may send you to a hospital specialist or straight to hospital.2 The main tests are blood tests and a bone marrow biopsy: a small sample of marrow is taken with a needle from the hip bone or breastbone, usually after numbing the skin.6,1 Gene tests on the leukaemia cells help choose the treatment.1 You may also need a lumbar puncture (a little fluid taken from the lower back) and scans.6 Blood results can come within a few days; other tests take a few weeks.6
Current treatment
Intensive chemo, sometimes a stem cell transplantSource: NHS
Will it get worse?
Without treatment, AML gets worse quickly, but it is often treatable.1,3 How serious it is depends on the type of AML, your age and your general health.4 In older people, the leukaemia may be less likely to go into remission.1 Even after remission, the leukaemia can come back, which is why treatment carries on afterwards.1 When AML cannot be cured, treatment aims to control it, ease symptoms and help you live longer.3
Medicines: what helps, and what to watch for
Chemotherapy is the main treatment, usually several medicines together.3 Intensive treatment aims to cure the leukaemia and is usually given in hospital.3 Non-intensive treatment aims to control it for as long as possible; it is usually given at home and has fewer side effects.3 Targeted medicines can be added, for example when the leukaemia has a change in the FLT3 gene.3,1 One type, acute promyelocytic leukaemia, may be treated with ATRA and arsenic trioxide.1
Good to know:
- Treatment comes in phases: first to clear the leukaemia from the blood and marrow, then more treatment to kill any cells that are left;1
- AML and chemotherapy lower your blood counts, so you are watched closely and may need blood and platelet transfusions;1
- You may get antibiotics and antifungal medicines to prevent or treat infections;1,3
- You have regular check-ups, tests and scans during and after treatment;3
Exercise and diet help too
Tiredness is one of the most common problems and can continue for months after treatment.7 After treatment, exercise can help your body and your mood: start gently, for example with walking, and build up slowly.8 You can go swimming once your white blood cell count is back to normal and you no longer have a central line.8 A good, balanced diet might help you feel stronger and recover more quickly.8 Your nurse can refer you to a dietitian or a physiotherapist.7
- After a stem cell transplant, your team may give you food-safety advice for the first few months, such as eating only freshly cooked food;8
A transplant, for some people
A stem cell or bone marrow transplant replaces the damaged blood-making cells with healthy ones.3,1 First you get high-dose chemotherapy, sometimes with radiotherapy, and then the stem cells are given back to you through an infusion.1 They can be your own cells or come from a donor.1 It may be offered if the leukaemia is likely to come back, has come back, or other treatments are not working.3
Is there a cure?
Sometimes.9,3 Intensive treatment aims to cure AML, and more than 1 in 4 adults live 3 years or more and may be cured.9,3 For others, treatment aims to keep it under control.3 New treatments are being tested in clinical trials.1
Median survival
About 15 months with azacitidine and venetoclax, for people who cannot have intensive chemotherapySource: The New England Journal of Medicine, 2020
Measured in: Previously untreated AML in people who could not have intensive chemotherapy (median age 76): the VIALE-A trial (431 patients)
The figures behind it
VIALE-A (431 previously untreated patients who were ineligible for intensive chemotherapy, median age 76): median overall survival 14.7 months with azacitidine plus venetoclax vs 9.6 months with azacitidine alone. People who can have intensive chemotherapy are not part of this figure.
Sources
Written in plain words by Frontlight from these pages:
- NCI PDQ: Acute Myeloid Leukemia Treatment (PDQ®) – Patient Version
- NHS: Acute myeloid leukaemia – Symptoms
- NHS: Acute myeloid leukaemia – Treatment
- NHS: Acute myeloid leukaemia – What is AML?
- NHS: Acute myeloid leukaemia – Causes
- NHS: Acute myeloid leukaemia – Tests and next steps
- Cancer Research UK (charity): Coping with acute myeloid leukaemia
- Cancer Research UK (charity): Diet and physical activity after AML
- NCI PDQ: Adult Acute Myeloid Leukemia Treatment (PDQ®) – Health Professional Version